Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 Pandemic on Ambulatory Pediatric Cardiology Care by Race, Ethnicity, and Socioeconomic Status.

Journal of pediatrics. Clinical practice·2026
Same author

Novel endoscopic cryoprobe extraction of acute food bolus impaction: a case report.

iGIE : innovation, investigation and insights·2026
Same author

BK Polyomavirus-Associated Kidney and Bladder Carcinomas Following Heart and Lung Transplantation in Childhood.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population.

Pediatric transplantation·2026
Same author

Fate of Discarded Hearts Donated After Circulatory Death: Is There an Opportunity for Novel Use?

Annals of thoracic surgery short reports·2025
Same author

Novel Use of Cryotherapy for Treatment and Diagnosis of Intrathoracic Nontuberculous Mycobacteria Infections in Children: A Case Series.

Pediatric pulmonology·2025

Related Experiment Video

Updated: Jun 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Induction therapy with antithymocyte globulin before reperfusion.

Samuel B Goldfarb1, J William Gaynor, Stephanie Fuller

  • 1Division of Pulmonary Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. goldfarb@email.chop.edu

The Annals of Thoracic Surgery
|September 28, 2010
PubMed
Summary
This summary is machine-generated.

Early administration of antilymphocyte globulin (ATG) before lung reperfusion in pediatric lung transplant recipients significantly reduced acute cellular rejection (ACR) incidence within six months post-transplant.

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Related Experiment Videos

Last Updated: Jun 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Area of Science:

  • Pediatric transplantation
  • Immunosuppression therapy
  • Pulmonary medicine

Background:

  • Induction immunosuppressive agents are not universally used in pediatric lung transplantation.
  • Rationale for induction therapy is to mitigate acute cellular rejection (ACR) risk during the early post-transplant period.
  • Timing of induction immunosuppression varies, prompting investigation into optimal protocols.

Purpose of the Study:

  • To evaluate the efficacy of early antilymphocyte globulin (ATG) administration prior to donor lung reperfusion in reducing ACR incidence in pediatric lung transplant recipients.
  • To assess the safety and effectiveness of a specific ATG induction protocol in a pediatric cohort.

Main Methods:

  • ATG was administered intraoperatively before reperfusion and continued for four days post-transplant.
  • Pediatric patients (n=18) were monitored for ACR using transbronchial biopsies within the first six months post-transplant.
  • ACR diagnosis followed International Society for Heart & Lung Transplantation guidelines.

Main Results:

  • A single episode of ACR (≥ grade A2) occurred in 18 patients, resulting in a 5.2% incidence rate.
  • Sixty-three flexible bronchoscopies with transbronchial biopsies were performed during the initial six months.
  • The study observed a low incidence of ACR in patients receiving ATG induction therapy.

Conclusions:

  • Pre-reperfusion induction therapy with ATG is associated with a low incidence of ACR in pediatric lung transplant recipients within the first six months.
  • Further long-term follow-up is necessary to determine the complete impact of this ATG induction protocol on transplant outcomes.